Who owns NEKTAR THERAPEUTICS?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NKTR from SEC Form 13F filings across 243 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 243 institutions disclosed 35.8M shares of NEKTAR THERAPEUTICS worth $2.17B — about 104.9% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
243
13F holders
$2.17B
value, 2026 filers
104.9%
of shares outstanding (35.8M sh)
44
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of NKTR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 5.1M | $310.1M | 0.0% | 15% | +1.1% |
| 2 | Two Seas Capital LP | 3.3M | $202.6M | 2.3% | 9.8% | +8.2% |
| 3 | BlackRock, Inc. | 2.9M | $173.9M | 0.0% | 8.4% | -2.4% |
| 4 | BVF INC/IL | 2.1M | $129.2M | 4.2% | 6.2% | -10.8% |
| 5 | STATE STREET CORP | 1.8M | $107.3M | 0.0% | 5.2% | +94.8% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | $90.9M | 0.0% | 4.4% | +0.3% |
| 7 | TWO SIGMA INVESTMENTS, LP | 1.2M | $73.2M | 0.1% | 3.5% | +0.5% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 891,927 | $54.0M | 0.0% | 2.6% | +1.2% |
| 9 | MORGAN STANLEY | 830,210 | $50.3M | 0.0% | 2.4% | -11.4% |
| 10 | Prosight Management, LP | 785,000 | $47.5M | 9.2% | 2.3% | -3.1% |
| 11 | ARMISTICE CAPITAL, LLC | 700,000 | $42.4M | 0.5% | 2% | -3.3% |
| 12 | GOLDMAN SACHS GROUP INC | 621,249 | $37.6M | 0.0% | 1.8% | +171.9% |
| 13 | BANK OF AMERICA CORP /DE/ | 544,805 | $33.0M | 0.0% | 1.6% | +799.6% |
| 14 | Vestal Point Capital, LP | 510,000 | $30.9M | 0.8% | 1.5% | -49.0% |
| 15 | GILDER GAGNON HOWE & CO LLC | 499,603 | $30.2M | 0.3% | 1.5% | -16.9% |
| 16 | Woodline Partners LP | 471,402 | $28.5M | 0.1% | 1.4% | +0.1% |
| 17 | BRAIDWELL LP | 443,591 | $26.9M | 1.1% | 1.3% | -6.3% |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 388,857 | $23.5M | 0.0% | 1.1% | +39.4% |
| 19 | ORBIMED ADVISORS LLC | 384,520 | $23.3M | 0.4% | 1.1% | -17.4% |
| 20 | EMERALD ADVISERS, LLC | 380,029 | $23.0M | 0.6% | 1.1% | -2.6% |
| 21 | VANGUARD PORTFOLIO MANAGEMENT LLC | 369,520 | $22.4M | 0.0% | 1.1% | +6.0% |
| 22 | DAFNA Capital Management LLC | 323,380 | $19.6M | 4.2% | 0.9% | +1.6% |
| 23 | Creek Drive Management Group LLC | 317,000 | $19.2M | 5.2% | 0.9% | +30.5% |
| 24 | NORTHERN TRUST CORP | 307,157 | $18.6M | 0.0% | 0.9% | -0.4% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 305,323 | $18.5M | 0.0% | 0.9% | +7.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.